ALNY•benzinga•
Alnylam Pharmaceuticals Reiterated 2024 Financial Guidance, Including Combined Net Product Revenues Of $1.575B-$1.65B
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga